Key Account Manager, aT1D - Western Canada

Reference No. R2772582​

Position Title: Key Account Manager, aT1D​

Department: National Ecosystem

Location: Western Canada (BC/ Alberta/Saskatchewan/Manitoba)​

About the Job

We are an innovative global healthcare company with a focus on immunology that extends to innovation in diabetes and transplant medicine. Across different countries, our talented teams are determined to deliver a best-in-class customer experience using the best of digital, artificial intelligence and personal know-how. With a focus on immunology that extends to innovation in diabetes and transplant medicines, we pursue progress to make a real impact on millions of patients around the world.

At Sanofi, we’ve redefined diabetes care many times since 1923. Sanofi is working at increasing awareness and support for people developing and diagnosed with autoimmune Type 1 Diabetes (aT1D). If you’re passionate about the future of diabetes support for thousands of people around the world, this is your opportunity to become part of our Sanofi’s aT1D team in Canada.

Successful candidates will be able to grow their scientific careers alongside fellow passionate colleagues, with a shared hunger to be part of the future in diabetes. With us, you’ll pioneer the change in support for patients and their families around the world.

The aT1D Key Account Manager is a full-time position within the Gen Med aT1D portfolio within a rapidly evolving Type 1 diabetes marketplace. Focused on the aT1D ecosystem, you will work alongside endocrinologists, internists, diabetes educators, primary care physicians & pharmacists.

You will develop and implement integrated business/account plans that deliver the budgeted revenue and proper utilization of resources, in major key accounts, including advocacy development, access, budget management and promotional material.

Main Responsibilities:

• Segmenting accounts (e.g., Centers of Excellence, referring centers, or other key accounts in the Autoimmune Type 1 diabetes local care pathway) and developing in-depth knowledge of each identified key account including strategic goals, value drivers, relevant business metrics, and unique emerging needs.

• Understanding key accounts’ critical stakeholders (e.g., endocrinology / immunology ‘C-suite’ executives and key decision makers), their roles, org structure and how they influence each other in to ensure account/departmental coordination.

• Developing understanding of target accounts (e.g., Centers of Excellence or other key accounts in the Autoimmune Type 1 diabetes local care pathway) functioning and existing screening/infusion infrastructure to identify operational barriers that could prevent patients from accessing screening or treatment administration.

• Developing strategic account plans including prioritization, based on identified barriers to address opportunities. Co-creating solutions with accounts’ …